Skip to content
Back to VRDN

Viridian Therapeutics, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
4
Purchases
1
Sales
3
Purchase value
$20.00M
Sale value
$418.99K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Jennifer TousignantChief Legal Officer
4
Filed Aug 20, 2026Period of report Aug 19, 20260001193125-26-359636
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 19, 2026
Common StockF14,212$24.50$103.19K0Direct
SaleAug 19, 2026
Common Stock10,000$24.50$245.00K0Direct
Filing footnotes · 2
  1. F1The shares sold include 718 shares previously acquired by the reporting person pursuant to the Viridian Therapeutics, Inc. Employee Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c).
  2. F2The option was granted on March 3, 2025 and vests in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date.
Open on SEC EDGAR
Funds Management LLC FairmountDirector · 10% owner
Healthcare Fund II GP LLC FairmountDirector · 10% owner
Healthcare Fund II L.P. FairmountDirector · 10% owner
4
Filed May 13, 2026Period of report May 11, 20260001104659-26-060294
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 11, 2026
Common StockF11,176,470$17.00$20.00M5,090,928IndirectBy Fairmount Healthcare Fund II L.P.
Filing footnotes · 1
  1. F1Fairmount Funds Management LLC ("Fairmount") and Fairmount Healthcare Fund II GP LLC ("Fairmount GP II") have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.
Open on SEC EDGAR
Jennifer TousignantChief Legal Officer
4
Filed Jan 2, 2026Period of report Dec 31, 20250001193125-26-001097
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 31, 2025
Common StockF12,272$31.16$70.80K0Direct
Filing footnotes · 1
  1. F1Consists of shares purchased under the Issuer's employee stock purchase plan.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.